|
Sex, male
|
1.09 [0.63–1.88]
|
0.818
|
–
|
–
|
|
Age > 60
|
1.03 [0.60–1.78]
|
0.908
| | |
|
ASA (I vs II + III + IV)
|
1.08 [0.60–1.94]
|
0.790
|
–
|
–
|
|
Stage (II vs III)
|
6.27 [2.13–17.39]
|
< 0.001
|
3.64 [1.14–11.67]
|
0.030
|
|
Vascular invasion
|
2.05 [1.09–3.84]
|
0.026
|
1.77 [0.92–3.37]
|
0.087
|
|
Lymphatic invasion
|
3.81 [1.72–8.44]
|
0.001
|
1.76 [0.70–4.43]
|
0.229
|
|
Pre-operative CEA level > 5
|
2.17 [1.25–3.75]
|
0.006
|
2.226 [1.28–3.87]
|
0.005
|
|
Neutrophil lymphocyte ratio ≥ 5
|
0.31 [0.35–1.34]
|
0.702
| | |
|
Differentiation (well vs moderate +poor)
|
1.70 [0.41–7.01]
|
0.461
|
–
|
–
|
|
BMI ≥ 25
|
0.69 [0.36–1.35]
|
0.265
|
–
|
–
|
|
Visceral obesity ≥ 130[33]
|
0.65 [0.34–1.27]
|
0.206
|
–
|
–
|
|
Subcutaneous fat area (cm2) > 92a
|
0.80 [0.47–1.37]
|
0.417
|
–
|
–
|
|
Abdominal circumference (cm) > 83a
|
0.89 [0.52–1.52]
|
0.663
|
–
|
–
|
|
CONUT score > 7[22]
|
0.91 [0.22–3.79]
|
0.892
|
–
|
–
|
|
Pre-sarcopenia, men < 46.4 cm2, women < 37.5 cm2 [32]
|
1.83 [1.08–3.22]
|
0.023
|
1.86 [1.04-3.13]
|
0.037
|
